Impaired muscarinic type 3 (M3) receptor/PKC and PKA pathways in islets from MSG-obese rats

Molecular Biology Reports

Volumn 40, Issue 7, 2013, Pages 4521-4528

  Ribeiro, Rosane Aparecida ^a   Balbo, Sandra Lucinei ^b   Roma, Letícia Prates ^c   Camargo, Rafael Ludemann ^c   Barella, Luiz Felipe ^b   Vanzela, Emerielle Cristine ^c   De Freitas Mathias, Paulo Cesar ^d   Carneiro, Everardo Magalhães ^c   Boschero, Antonio Carlos ^c   Bonfleur, Maria Lúcia ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Insulin secretion; M3; Monosodium glutamate; Obesity; PKA; PKC

Indexed keywords

CARBACHOL; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 2; GLUTAMATE SODIUM; ISOBUTYLMETHYLXANTHINE; MUSCARINIC M3 RECEPTOR; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; SODIUM CHLORIDE; GERMINAL CENTER KINASES; GLUCOSE BLOOD LEVEL; INSULIN; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; CELL FUNCTION; CONTROLLED STUDY; GLUCOSE INTOLERANCE; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NEWBORN; NONHUMAN; OBESITY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; RAT; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; GLUCOSE BLOOD LEVEL; METABOLISM; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

RATTUS; RATTUS NORVEGICUS; RODENTIA;

ANIMALS; BLOOD GLUCOSE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; GLUCOSE; GLUCOSE TRANSPORTER TYPE 2; INSULIN; ISLETS OF LANGERHANS; MALE; OBESITY; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; RATS; RECEPTOR, MUSCARINIC M3; SIGNAL TRANSDUCTION; SODIUM GLUTAMATE;

EID: 84879377683     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2546-y     Document Type: Article

References (36)

1. Tengholm A, Gylfe E (2009) Oscillatory control of insulin secretion. Mol Cell Endocrinol 297(1-2):58-72
2. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97-S107
3. Ribeiro RA, Santos-Silva JC, Vettorazzi JF, Cotrim BB, Mobiolli DD, Boschero AC, Carneiro EM (2012) Taurine supplementation prevents morpho-physiological alterations in high-fat diet mice pancreatic beta-cells. Amino Acids 43(4):1791-1801
4. Ahren B (2000) Autonomic regulation of islet hormone secretion- implications for health and disease. Diabetologia 43(4):393-410
5. Olney JW, Sharpe LG (1969) Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science 166(3903):386-388
6. Maiter D, Underwood LE, Martin JB, Koenig JI (1991) Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats. Endocrinology 128(2):1100-1106
7. Martins AC, Souza KL, Shio MT, Mathias PC, Lelkes PI, Garcia RM (2004) Adrenal medullary function and expression of catecholamine-synthesizing enzymes in mice with hypothalamic obesity. Life Sci 74(26):3211-3222
8. Balbo SL, Grassiolli S, Ribeiro RA, Bonfleur ML, Gravena C, Brito Mdo N, Andreazzi AE, Mathias PC, Torrezan R (2007) Fat storage is partially dependent on vagal activity and insulin secretion of hypothalamic obese rat. Endocrine 31(2):142-148
9. Lucinei Balbo S, Gravena C, Bonfleur ML, de Freitas Mathias PC (2000) Insulin secretion and acetylcholinesterase activity in monosodium l-glutamate-induced obese mice. Horm Res 54(4):186-191
10. Balbo SL, Bonfleur ML, Carneiro EM, Amaral ME, Filiputti E, Mathias PC (2002) Parasympathetic activity changes insulin response to glucose and neurotransmitters. Diabetes Metab 28(6 Pt 2):13-17 discussion 13S108-112
11. Nardelli TR, Ribeiro RA, Balbo SL, Vanzela EC, Carneiro EM, Boschero AC, Bonfleur ML (2011) Taurine prevents fat deposition and ameliorates plasma lipid profile in monosodium glutamate-obese rats. Amino Acids 41(4):901-908
12. Paes AM, Carniatto SR, Francisco FA, Brito NA, Mathias PC (2006) Acetylcholinesterase activity changes on visceral organs of VMH lesion-induced obese rats. Int J Neurosci 116(11):1295-1302
13. Mitrani P, Srinivasan M, Dodds C, Patel MS (2007) Autonomic involvement in the permanent metabolic programming of hyperinsulinemia in the high-carbohydrate rat model. Am J Physiol Endocrinol Metab 292(5):E1364-E1377
14. Scomparin DX, Gomes RM, Grassiolli S, Rinaldi W, Martins AG, de Oliveira JC, Gravena C, de Freitas Mathias PC (2009) Autonomic activity and glycemic homeostasis are maintained by precocious and low intensity training exercises in MSG-programmed obese mice. Endocrine 36(3):510-517
15. Andreazzi AE, Scomparin DX, Mesquita FP, Balbo SL, Gravena C, De Oliveira JC, Rinaldi W, Garcia RM, Grassiolli S, Mathias PC (2009) Swimming exercise at weaning improves glycemic control and inhibits the onset of monosodium l-glutamate-obesity in mice. J Endocrinol 201(3):351-359
16. Bernardis LL, Patterson BD (1968) Correlation between 'Lee index' and carcass fat content in weanling and adult female rats with hypothalamic lesions. J Endocrinol 40(4):527-528
17. 2+ handling in mouse pancreatic islets. Br J Nutr 104(8):1148-1155
18. Harms PG, Ojeda SR (1974) A rapid and simple procedure for chronic cannulation of the rat jugular vein. J Appl Physiol 36(3):391-392
19. Bergmeyer HU, Bernt E (1974) Determination of glucose with glucose oxidase and peroxidase. In: Bergeyer HU (ed) Methods of enzymatic analysis. Verlag Chemie, Weinhein, pp 1105-1212
20. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23(1):57-63
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412-419
22. Straub SG, Sharp GW (2002) Glucose-stimulated signaling pathways in biphasic insulin secretion. Diabetes Metab Res Rev 18(6):451-463
23. + ATP channel-dependent but not-independent pathways on glucose-induced insulin release process. Endocrine 30(2):191-196
24. Wu G, Morris SM Jr (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336(Pt 1):1-17
25. Gilon P, Henquin JC (2001) Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev 22(5):565-604
26. Grassiolli S, Gravena C, de Freitas Mathias PC (2007) Muscarinic M2 receptor is active on pancreatic islets from hypothalamic obese rat. Eur J Pharmacol 556(1-3):223-228
27. Gautam D, Han SJ, Hamdan FF, Jeon J, Li B, Li JH, Cui Y, Mears D, Lu H, Deng C, Heard T, Wess J (2006) A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 3(6):449-461
28. Leech CA, Castonguay MA, Habener JF (1999) Expression of adenylyl cyclase subtypes in pancreatic beta-cells. Biochem Biophys Res Commun 254(3):703-706
29. Delmeire D, Flamez D, Hinke SA, Cali JJ, Pipeleers D, Schuit F (2003) Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1. Diabetologia 46(10):1383-1393
30. 2+ channel in a murine pancreatic beta-cell line. Diabetes 45(10):1412-1418
31. Seino S, Shibasaki T (2005) PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol Rev 85(4):1303-1342
32. Dolz M, Bailbe D, Giroix MH, Calderari S, Gangnerau MN, Serradas P, Rickenbach K, Irminger JC, Portha B (2005) Restitution of defective glucose-stimulated insulin secretion in diabetic GK rat by acetylcholine uncovers paradoxical stimulatory effect of beta-cell muscarinic receptor activation on cAMP production. Diabetes 54(11):3229-3237
33. Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, Holst JJ (2001) Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 86(8):3717-3723
34. Ferreira F, Barbosa HC, Stoppiglia LF, Delghingaro-Augusto V, Pereira EA, Boschero AC, Carneiro EM (2004) Decreased insulin secretion in islets from rats fed a low protein diet is associated with a reduced PKAalpha expression. J Nutr 134(1):63-67
35. Bonfleur ML, Ribeiro RA, Balbo SL, Vanzela EC, Carneiro EM, de Oliveira HC, Boschero AC (2011) Lower expression of PKAalpha impairs insulin secretion in islets isolated from low-density lipoprotein receptor (LDLR(-/-)) knockout mice. Metabolism 60(8):1158-1164
36. Wajchenberg BL (2007) Beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev 28(2):187-218 Tecnológico Nível Superior